Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Celularity Inc CELU
$0.71
▼ -6.34%
($-0.05)
⬇️ Below Yest. Low
⚡ High Volume
🎈 Low Float
📅 Earnings This Week
Open
$0.76
Prev Close
$0.76
Day Range
$0.71 – $0.76
52W Range
$0.56 – $2.55
Market Cap
$24.65M
Beta
1.01
EPS (TTM)
$-3.59
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-23 |
| Shares Out. | 32,450,000 |
| Website | celularity.com/ ↗ |
| Phone | 18009279800 |
| Employees | 115 |
| Revenue | $5.4M |
| Gross Profit | $3.1M |
| Net Income | $706,000 |
| Free Cash Flow | -$8.9M |
| Total Assets | $96.2M |
| Total Liabilities | $131.7M |
| Equity | -$35.5M |
About Celularity Inc
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Celularity Inc is a publicly traded company under the ticker symbol CELU on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-09-01)